Adamas Pharmaceuticals - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsAdamas Pharmaceuticals

Adamas Pharmaceuticals(ADMS)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

Quarterly

Quarterly

Annual

Annual

Projections

*Quarterly sales USD (in millions)

Plot placeholder

Mock data
Subscribe for the real data

Revenue by Drug

Marketed Drugs

No data

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

therapeutic equivalency

,

,

,

biological availability

,

,

,

non-hodgkin lymphoma

,

,

precursor cell lymphoblastic leukemia-lymphoma

,

lymphoid leukemia

,

retinal detachment

,

vascular diseases

,

macular degeneration

,

wet macular degeneration

,

polypoidal choroidal vasculopathy

,

alzheimer disease

,

,

borrelia infections

,

rheumatoid arthritis

,

,

,

,

small cell lung carcinoma

,

streptococcal infections

,

prostatic neoplasms

,

type 2 diabetes mellitus

,

diabetes mellitus

,

,

renal cell carcinoma

,

,

hepatocellular carcinoma

,

,

liver neoplasms

,

gastrointestinal stromal tumors

,

,

multiple sclerosis

,

,

,

multiple organ failure

,

,

facial paralysis

,

,

premature birth

,

bacterial vaginosis

,

vaginal diseases

,

,

venous thromboembolism

,

,

venous thrombosis

,

pulmonary embolism

,

,

intracranial thrombosis

,

thromboembolism

,

intracranial sinus thrombosis

,

,

,

contact dermatitis

,

bacterial skin diseases

,

,

,

asymptomatic infections

Microcrystalline cellulose

,

therapeutic equivalency

,

,

,

,

hematologic neoplasms

,

non-hodgkin lymphoma

,

,

hodgkin disease

,

,

lupus nephritis

,

systemic lupus erythematosus

,

,

multiple sclerosis

,

healthy volunteers/patients

,

,

,

atrophic vaginitis

human influenza

influenza in birds

,

,

multiple sclerosis

,

,

,

,

,

orthomyxoviridae

,

,

communicable diseases

,

infectious myxomatosis

,

h1n1 subtype influenza a virus

,

,

,

,

,

viral hemorrhagic fevers

,

,

,

,

,

,

,

meningococcal infections

,

,

haemophilus influenzae type b

,

inactivated vaccines

,

,

human influenza

,

orthomyxoviridae infections

,

healthy volunteers/patients

,

,

,

myocardial infarction

,

,

multiple myeloma

,

plasma cell neoplasms

,

,

chronic obstructive pulmonary disease

,

,

obstructive lung diseases

,

,

,

immune system diseases

,

pregnancy complications

,

,

toxicological phenomena

,

,

respiratory syncytial virus infections

,

,

,

,

atrial fibrillation

,

cardiovascular diseases

,

coronary disease

,

cardiac arrhythmias

,

,

,

diabetes mellitus

,

respiratory tract infections

,

inferior wall myocardial infarction

,

severe acute respiratory syndrome

,

behavior and behavior mechanisms

,

influenza in birds

,

,

multiple sclerosis

,

,

,

,

,

orthomyxoviridae

,

,

communicable diseases

,

infectious myxomatosis

,

h1n1 subtype influenza a virus

,

,

,

,

,

viral hemorrhagic fevers

,

,

,

,

,

,

,

meningococcal infections

,

,

haemophilus influenzae type b

,

inactivated vaccines

,

,

human influenza

,

orthomyxoviridae infections

,

healthy volunteers/patients

,

,

,

myocardial infarction

,

,

multiple myeloma

,

plasma cell neoplasms

,

,

chronic obstructive pulmonary disease

,

,

obstructive lung diseases

,

,

,

immune system diseases

,

pregnancy complications

,

,

toxicological phenomena

,

,

respiratory syncytial virus infections

,

,

,

,

atrial fibrillation

,

cardiovascular diseases

,

coronary disease

,

cardiac arrhythmias

,

,

,

diabetes mellitus

,

respiratory tract infections

,

inferior wall myocardial infarction

,

severe acute respiratory syndrome

,

behavior and behavior mechanisms

,

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use